Lansoprazole Biogaran

Lansoprazole, the active ingredient in Lansoprazole Biogaran, is a proton pump inhibitor presented as a tablet for oral use. It reduces gastric acid secretion and is used to treat gastro‑oesophageal reflux disease, peptic ulcer disease and as part of Helicobacter pylori eradication regimens.

GNH USA supplies Lansoprazole Biogaran as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lansoprazole is a proton pump inhibitor indicated for several acid‑related conditions.

- Gastro‑oesophageal reflux disease (GERD): provides symptomatic relief by decreasing stomach acidity. - Peptic ulcer disease: promotes ulcer healing and prevents recurrence through acid suppression. - Helicobacter pylori eradication (in combination therapy): enhances the effectiveness of antibiotic regimens by creating a less acidic gastric environment.

Lansoprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: usually transient. - Nausea: occasional, may improve with continued use. - Abdominal pain: mild discomfort. - Flatulence: increased gas. - Constipation: occasional bowel habit change.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): requires immediate medical attention. - Clostridioides difficile infection: presents with watery diarrhea. - Low magnesium levels (hypomagnesemia): can cause muscle cramps or arrhythmia. - Liver injury: indicated by jaundice or elevated liver enzymes. - Interstitial nephritis: renal inflammation presenting with reduced urine output.

Before initiating therapy, consider the following safety measures.

- Renal function assessment: adjust use in severe impairment. - Magnesium monitoring: check levels during prolonged treatment. - Elderly patients: start with the lowest effective dose. - Concomitant medications: review for potential interactions, especially with drugs requiring acidic pH. - Pregnancy and lactation: use only if clearly needed, as safety data are limited. - Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Lansoprazole may affect the pharmacokinetics of several co‑administered drugs.

Major Interactions (Avoid): - Clarithromycin: increased risk of cardiac arrhythmias. - Ketoconazole: markedly reduced antifungal absorption. - Atazanavir: diminished antiviral efficacy. - HIV protease inhibitors (e.g., ritonavir): decreased plasma concentrations. - Warfarin: potential alteration of anticoagulant effect.

Moderate Interactions (Monitor Closely): - Digoxin: modest increase in serum levels. - Methotrexate: possible accumulation, especially at high doses. - Phenytoin: reduced anticonvulsant levels. - Theophylline: may increase plasma concentration. - Iron supplements: decreased iron absorption; separate dosing by at least 2 hours.